Takashi Kojima Selected Research

Takashi Kojima Research Topics

Disease

89	Neoplasms (Cancer) 11/2022 - 01/2002
42	Esophageal Squamous Cell Carcinoma 11/2022 - 01/2011
35	Esophageal Neoplasms (Esophageal Cancer) 10/2022 - 12/2007
29	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 08/2003
21	Stomach Neoplasms (Stomach Cancer) 07/2022 - 12/2003
16	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 01/2011
16	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2007
16	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 08/2010
15	Inflammation (Inflammations) 01/2022 - 01/2006
13	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2002
13	Infections 02/2021 - 05/2002
12	Adenocarcinoma 10/2022 - 01/2009
11	Endometrial Neoplasms (Endometrial Cancer) 12/2021 - 11/2013
8	Cataract (Cataracts) 01/2020 - 03/2004
7	Disease Progression 08/2022 - 01/2009
7	Allergic Rhinitis 08/2021 - 05/2005
7	Carcinoma (Carcinomatosis) 07/2020 - 04/2003
7	Respiratory Syncytial Virus Infections 01/2016 - 01/2011
6	Carcinogenesis 05/2022 - 09/2006
5	Retinal Detachment (Retinal Detachments) 03/2022 - 01/2017
5	Myopia 01/2022 - 04/2008
5	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2012
5	Proteinuria 01/2020 - 12/2009
4	Keratoconus 01/2022 - 07/2013
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2006
4	Sepsis (Septicemia) 01/2022 - 10/2010
4	Wounds and Injuries (Trauma) 01/2022 - 01/2009
4	Hypoxia (Hypoxemia) 01/2022 - 07/2011
4	Neutropenia 01/2022 - 12/2019
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 10/2016
4	Retinal Perforations 05/2021 - 09/2010
4	Febrile Neutropenia 02/2021 - 08/2011
4	Astigmatism 10/2019 - 01/2008
4	Fibrosis (Cirrhosis) 12/2018 - 05/2012
4	Pathologic Constriction (Stenosis) 01/2018 - 01/2011
4	Keratoconjunctivitis 11/2014 - 09/2008

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 11/2022 - 02/2003
23	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 08/2002
22	Tight Junction ProteinsIBA 12/2021 - 07/2003
19	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2008
16	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2011
16	Claudin-4IBA 01/2019 - 12/2004
13	CytokinesIBA 01/2022 - 01/2006
12	Docetaxel (Taxotere)FDA Link 01/2022 - 11/2010
11	Claudin-1IBA 11/2016 - 07/2003
10	OccludinIBA 01/2020 - 12/2004
9	NivolumabIBA 01/2022 - 01/2017
9	ClaudinsIBA 12/2021 - 08/2006
9	Ophthalmic Solutions (Eye Drops)IBA 05/2020 - 02/2005
9	Pharmaceutical PreparationsIBA 01/2020 - 03/2008
8	pembrolizumabIBA 10/2022 - 01/2019
8	Lipoprotein Receptors (Lipoprotein Receptor)IBA 12/2021 - 05/2016
8	MARVEL Domain Containing 2 ProteinIBA 08/2020 - 08/2011
8	Messenger RNA (mRNA)IBA 01/2020 - 07/2011
7	Immune Checkpoint InhibitorsIBA 09/2022 - 05/2017
7	Monoclonal AntibodiesIBA 01/2021 - 07/2012
7	Irinotecan (Camptosar)FDA LinkGeneric 12/2020 - 12/2008
6	Histone Deacetylase InhibitorsIBA 05/2022 - 10/2007
6	HMGB1 Protein (HMG1)IBA 01/2022 - 01/2020
6	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 11/2018
6	Small Interfering RNA (siRNA)IBA 11/2020 - 09/2011
6	diquafosolIBA 07/2020 - 07/2013
6	Clostridium enterotoxinIBA 11/2013 - 09/2011
5	AntigensIBA 11/2022 - 05/2005
5	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 02/2016
5	regorafenibIBA 01/2022 - 12/2016
5	trifluridine tipiracil drug combinationIBA 01/2022 - 01/2016
5	PlatinumIBA 01/2022 - 01/2017
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016 - 01/2007
5	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2014 - 01/2011
4	Histone Deacetylases (Histone Deacetylase)IBA 05/2022 - 01/2017
4	Retinaldehyde (Retinal)IBA 03/2022 - 05/2007
4	Indicators and Reagents (Reagents)IBA 11/2021 - 10/2010
4	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2009
4	LigandsIBA 01/2021 - 02/2007
4	LipidsIBA 01/2021 - 11/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 01/2009
4	SodiumIBA 07/2020 - 04/2018
4	rebamipideIBA 08/2019 - 11/2013
4	CreatinineIBA 10/2018 - 11/2016
4	ErbB Receptors (EGF Receptor)IBA 04/2016 - 08/2012
4	Phosphotransferases (Kinase)IBA 04/2016 - 07/2003
4	InterferonsIBA 01/2016 - 01/2006
4	Protein Kinase CIBA 08/2014 - 07/2011
4	Thymic Stromal LymphopoietinIBA 01/2014 - 06/2012

Therapy/Procedure

52	Therapeutics 11/2022 - 05/2007
38	Drug Therapy (Chemotherapy) 10/2022 - 07/2007
23	Chemoradiotherapy 08/2022 - 12/2007
11	Esophagectomy 10/2022 - 10/2012
9	Neoadjuvant Therapy 07/2020 - 08/2013
7	Radiotherapy 04/2022 - 12/2016
6	Aftercare (After-Treatment) 01/2021 - 10/2007
6	Endoscopes 01/2021 - 10/2012
5	Phakic Intraocular Lenses 01/2022 - 04/2012
5	Immunotherapy 01/2022 - 07/2011
5	Lasers (Laser) 07/2020 - 01/2008
4	Laser In Situ Keratomileusis (LASIK) 04/2022 - 04/2008
4	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2019
4	Induction Chemotherapy 02/2021 - 07/2016
4	Photochemotherapy (Photodynamic Therapy) 01/2020 - 09/2012